383 related articles for article (PubMed ID: 30832685)
21. Vascular Analysis of Soft Tissues Around the Bone Lesion in Osteoradionecrosis, Medication-Related Osteonecrosis, and Infectious Osteomyelitis of the Jaw.
Wang Z; Xu J; Wan J; Zhang W; Wang Y; Du Y
J Craniofac Surg; 2022 Oct; 33(7):e750-e754. PubMed ID: 36201691
[TBL] [Abstract][Full Text] [Related]
22. Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences.
Grisar K; Schol M; Schoenaers J; Dormaar T; Coropciuc R; Vander Poorten V; Politis C
Int J Oral Maxillofac Surg; 2016 Dec; 45(12):1592-1599. PubMed ID: 27427547
[TBL] [Abstract][Full Text] [Related]
23. Which symptoms negatively affect the oral health-related quality of life in patients with osteonecrosis of the jaw?
Sato T; Kusumoto J; Takeda D; Kishimoto M; Kashin M; Furudoi S; Akashi M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug; 130(2):175-180. PubMed ID: 32493679
[TBL] [Abstract][Full Text] [Related]
24. The effect of drug holiday on preventing medication-related osteonecrosis of the jaw in osteoporotic rat model.
Zhu WY; Yang WF; Wang L; Lan X; Tao ZY; Guo J; Xu J; Qin L; Su YX
J Orthop Translat; 2023 Mar; 39():55-62. PubMed ID: 36721766
[TBL] [Abstract][Full Text] [Related]
25. Comparison of maximum and mean standardized uptake values of jaw pathologies with bone SPECT/CT: an especial focus on medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
Nucl Med Commun; 2022 Dec; 43(12):1188-1194. PubMed ID: 36345763
[TBL] [Abstract][Full Text] [Related]
26. [The role of semaphorin 4D in the mechanism of bisphosphonate-related osteonecrosis of the jaw in rats].
Pan QT; Zang XL; Sun ZW; Pan MQ; Zhu XM; Li ZY
Shanghai Kou Qiang Yi Xue; 2022 Dec; 31(6):625-631. PubMed ID: 36970799
[TBL] [Abstract][Full Text] [Related]
27. Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw.
Li J; Wang W
J Stomatol Oral Maxillofac Surg; 2020 Jun; 121(3):264-267. PubMed ID: 31863928
[TBL] [Abstract][Full Text] [Related]
28. Quantitation and distribution of metallic elements in sequestra of medication-related osteonecrosis of jaw (MRONJ) using inductively coupled plasma atomic emission spectroscopy and synchrotron radiation X-ray fluorescence analysis.
Komiya R; Wada T; Tsushima F; Sakamoto K; Ikeda T; Yamaguchi A; Harada H; Uo M
J Bone Miner Metab; 2019 Jul; 37(4):676-684. PubMed ID: 30465092
[TBL] [Abstract][Full Text] [Related]
29. Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.
Yuan A; Munz A; Reinert S; Hoefert S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Feb; 129(2):133-140. PubMed ID: 31606424
[TBL] [Abstract][Full Text] [Related]
30. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
[TBL] [Abstract][Full Text] [Related]
31. Impaired Callus Formation in Pathological Mandibular Fractures in Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis.
Van Camp N; Verhelst PJ; Nicot R; Ferri J; Politis C
J Oral Maxillofac Surg; 2021 Sep; 79(9):1892-1901. PubMed ID: 34097863
[TBL] [Abstract][Full Text] [Related]
32. Image findings of bisphosphonate related osteonecrosis of jaws comparing with osteoradionecrosis.
Obinata K; Shirai S; Ito H; Nakamura M; Carrozzo M; Macleod I; Carr A; Yamazaki Y; Tei K
Dentomaxillofac Radiol; 2017 Jul; 46(5):20160281. PubMed ID: 28186845
[TBL] [Abstract][Full Text] [Related]
33. A commentary on "Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral Maxillofac. Surg. 41 (2012) 283-289].
Kalmar JR
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):147-8. PubMed ID: 23107998
[No Abstract] [Full Text] [Related]
34. Impacts of bisphosphonates on the bone and its surrounding tissues: mechanistic insights into medication-related osteonecrosis of the jaw.
Srivichit B; Thonusin C; Chattipakorn N; Chattipakorn SC
Arch Toxicol; 2022 May; 96(5):1227-1255. PubMed ID: 35199244
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones.
Li YF; Hu J
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):149-50. PubMed ID: 22763138
[No Abstract] [Full Text] [Related]
36. Histomorphologic characteristics of bisphosphonate-related osteonecrosis of the jaw.
Koerdt S; Dax S; Grimaldi H; Ristow O; Kuebler AC; Reuther T
J Oral Pathol Med; 2014 Jul; 43(6):448-53. PubMed ID: 24456519
[TBL] [Abstract][Full Text] [Related]
37. Response to - a commentary on "Suppurative osteomyelitis, bisphosphonate induced 1 osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its 2 implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral. Maxillofac. Surg. 41 (3) (2012) 283-289].
Marx RE; Tursun R
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):148-9. PubMed ID: 23219001
[No Abstract] [Full Text] [Related]
38. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
[TBL] [Abstract][Full Text] [Related]
39. Connective tissue growth factor (CTGF) regulates the fusion of osteoclast precursors by inhibiting Bcl6 in periodontitis.
Choi Y; Yoo JH; Lee JH; Lee Y; Bae MK; Kim YD; Kim HJ
Int J Med Sci; 2020; 17(5):647-656. PubMed ID: 32210715
[TBL] [Abstract][Full Text] [Related]
40. Zoledronate Inhibits Osteoclast Differentiation via Suppressing Vascular Endothelial Growth Factor Receptor 2 Expression.
Nakagawa T; Ohta K; Uetsuki R; Kato H; Naruse T; Murodumi H; Yokoyama S; Sakuma M; Ono S; Takechi M
Biochem Genet; 2020 Jun; 58(3):473-489. PubMed ID: 32274606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
